[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2214343A1 - Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate - Google Patents

Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate

Info

Publication number
CA2214343A1
CA2214343A1 CA002214343A CA2214343A CA2214343A1 CA 2214343 A1 CA2214343 A1 CA 2214343A1 CA 002214343 A CA002214343 A CA 002214343A CA 2214343 A CA2214343 A CA 2214343A CA 2214343 A1 CA2214343 A1 CA 2214343A1
Authority
CA
Canada
Prior art keywords
sodium alginate
potassium bicarbonate
pharmaceutical compositions
aqueous pharmaceutical
liquid aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002214343A
Other languages
French (fr)
Other versions
CA2214343C (en
Inventor
Paul Frederick Field
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504599.3A external-priority patent/GB9504599D0/en
Application filed by Individual filed Critical Individual
Publication of CA2214343A1 publication Critical patent/CA2214343A1/en
Application granted granted Critical
Publication of CA2214343C publication Critical patent/CA2214343C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use of potassium bicarbonate for the preparation of an aqueous pourable liquid composition comprising at least 8 % sodium alginate for use as a pharmaceutical.
CA002214343A 1995-03-03 1996-02-16 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate Expired - Fee Related CA2214343C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions
GB9504599.3 1995-03-03
PCT/GB1996/000358 WO1996027368A1 (en) 1995-03-03 1996-02-16 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate

Publications (2)

Publication Number Publication Date
CA2214343A1 true CA2214343A1 (en) 1996-09-12
CA2214343C CA2214343C (en) 2007-05-01

Family

ID=38051353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002214343A Expired - Fee Related CA2214343C (en) 1995-03-03 1996-02-16 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate

Country Status (1)

Country Link
CA (1) CA2214343C (en)

Also Published As

Publication number Publication date
CA2214343C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU1139097A (en) Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
AU6878294A (en) Pharmaceutical compositions having good dissolution properties
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
AU5115393A (en) Novel derivatives of taxol analogues, preparation thereof and compositions containing them
IL110793A0 (en) Benzofuran derivatives, their preparation and pharmaceutical compositions containing them
AU4724496A (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
AU1457995A (en) Novel adenosine derivatives, preparation methods therefor, and pharmaceutical compositions containing same
IL116916A (en) Substituted biphenyl sulfonamide derivatives and pharmaceutical compositions containing the same
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
AU4171493A (en) Stabilized built aqueous liquid softergent compositions
AU5541290A (en) Pharmaceutical compositions
IL108636A0 (en) Polysubstitued 2-amino-thiazole derivatives, their preparation and pharmaceutical compositions containing them
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
AUPN029994A0 (en) Alkypolysaccharide derivatives & compositions
AU8146994A (en) Novel taxicine derivatives, their preparation and pharmaceutical compositions containing them
AU3942297A (en) Pharmaceutical compositions containing 4-oxobutanoic acids
AU6787994A (en) Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
AU4075693A (en) Novel dihydroxybenzylamine derivatives, their preparation and pharmaceutical compositions containing same
AU3690495A (en) Pharmaceutical composition containing derivatives of sex hormones
CA2214343A1 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
AU1200495A (en) Ranitidine compositions
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150216